Prostate cancer places a significant physical and emotional burden on patients and families across India.

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while ...

Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

The FDA has approved capivasertib (Truqap) in combination with abiraterone acetate (Zytiga) and prednisone for adults with ...

You might go to Pocono Raceway for the action, but you might leave with something far more valuable. Man Cave Health is set ...

MultiValent Biotherapies, Inc. (MultiValent), a private biotechnology company developing targeted drug conjugate therapies for cancer, announced a $27.425 million first closing of its Series A ...

It follows a recommendation by health experts that only a small group of men should be screened.

AstraZeneca’s Truqap (capivasertib) gained FDA approval, combined with abiraterone and prednisone, for treatment of certain ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.

Australian men of all ages will soon be able to receive blood tests for prostate cancer as part of major changes to how the disease is diagnosed. Craig Watts, 61, was diagnosed with prostate cancer ...

Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...